NCT02268981View on ClinicalTrials.gov

Effects of an Oxymizer® During Daytime in Patients With Pulmonary Fibrosis (IPF)

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DEVICE

Oxymizer® compared to CNC

Oxygen Saturation measurement for 12 h with CNC

DEVICE

Oxymizer® compared to CNC

Oxygen Saturation measurement for 12 h with Oxymizer®

DEVICE

Oxymizer® compared to CNC

Saturation measurement for 12 h with Oxymizer® by reduced flow rate (-1l/min)

Trial Locations (1)

83471

Klinikum Berchtesgadener Land der Schön-Kliniken, Schönau am Königssee

All Listed Sponsors
lead

Schön Klinik Berchtesgadener Land

OTHER

NCT02268981 - Effects of an Oxymizer® During Daytime in Patients With Pulmonary Fibrosis (IPF) | Biotech Hunter | Biotech Hunter